Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium
about
Therapy of human papillomavirus-related diseaseResident memory T cells in human health and diseaseStrain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions.HPV Infection-Associated Cancers: Next-Generation Technology for Diagnosis and TreatmentToll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγHPV associated tumor cells control tumor microenvironment and leukocytosis in experimental modelsImmunoprevention of human papillomavirus-associated malignanciesLocal administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation.Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors.Epithelial cell responses to infection with human papillomavirus.Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital TractThe immune response to papillomavirus during infection persistence and regression.Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach.Immunotherapy of human papilloma virus induced diseaseLocation and Density of Immune Cells in Precursor Lesions and Cervical Cancer.Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinomaCurrent therapeutic vaccination and immunotherapy strategies for HPV-related diseases.The frequency of α₄β₇(high) memory CD4⁺ T cells correlates with susceptibility to rectal simian immunodeficiency virus infection.Virus-like particles for the prevention of human papillomavirus-associated malignancies.Immunotherapy in preneoplastic disease: targeting early procarcinogenic inflammatory changes that lead to immune suppression and tumor tolerance.Moving forward with human papillomavirus immunotherapies.Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study.Koch Institute Symposium on Cancer Immunology and ImmunotherapyPD-L1 limits the mucosal CD8+ T cell response to Chlamydia trachomatis.Recent advances in understanding and preventing human papillomavirus-related disease.Immune predictors of cancer progression.Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy.Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer.The interplay between HPV and host immunity in head and neck squamous cell carcinoma.Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapy.Coinjection of IL2 DNA enhances E7-specific antitumor immunity elicited by intravaginal therapeutic HPV DNA vaccination with electroporation.Novel Approaches for Vaccination Against HPV-Induced Cancers.Tumour virus vaccines: hepatitis B virus and human papillomavirus.Local and systemic immunomodulatory mechanisms triggered by Human Papillomavirus transformed cells: a potential role for G-CSF and neutrophils.Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers.Human papilloma virus status of penile squamous cell carcinoma is associated with differences in tumour-infiltrating T lymphocytes.
P2860
Q27007473-2EA0298E-32B0-4E92-A8F3-52CE5E22D0A2Q27025906-C8DBF02B-A39D-4358-B6BC-EB0F3F8B7E2EQ27324289-C01921DF-99EB-4889-A2CB-69DF6048465EQ33862762-731DE78F-A560-48E5-A491-9323795FE3BEQ34290170-92091B5D-26C5-4B93-94D1-6B075A6F4AA4Q34438411-823CFB3D-54A4-4754-8488-8FD3F8021E85Q34442828-3DC47F30-954D-4D5B-B3C9-4B30CD96F143Q35044376-DB77EA58-58E3-4ABC-B2F9-B37B6DFA4232Q35181633-D8B927B0-375D-466F-8EBB-8C83DFEACF4FQ35812239-7B97D618-7347-4673-A689-519E3C70DD7BQ35940596-DABF6A43-523E-49E8-A792-622F0A509C8FQ36081369-B29AC3C4-4519-4823-AF80-5115F0DCFF47Q36498016-35C66150-79EB-4139-8059-0E31FE555621Q36535555-95A8D637-9A11-4AC6-86F6-479E7936F49EQ36540399-665A722D-C35C-4EC4-B642-C6E3772417BAQ36540533-D2F378B9-2A69-40CD-B1ED-EC0FE44453B8Q36541008-4B3BB40E-1919-43CE-A56C-2A2125D82F8EQ36695065-AA637137-65BD-4C6F-BA1C-E71B6E2C738DQ37049751-C4E3A275-0636-4BBE-B729-0413578C0875Q37135023-5577134F-0D55-4F3F-81B9-07091EEC4CDDQ37273768-A87049EB-F91F-49E9-B628-7998503402ACQ37328475-ACA76B78-7D3C-42FE-8B71-CE4DD887FDCAQ37383212-1B324E6A-E9C1-4A44-B7E4-EA7EB5D9EE5DQ37473299-56D01A4E-1C8D-4599-88BB-3BD9DC173B65Q37484148-D615CD9D-3121-47F5-93AE-F45B40575580Q37500940-8A598574-8A42-4AA7-9B69-08C255E26AECQ37578957-58816E21-7613-4B40-95B0-C2F76834146FQ37709706-37DAEC7C-BCC6-462C-A286-F5E13966B2C2Q37992547-42963963-F86F-4F7C-A93E-9E81A0640A22Q38036688-A536A9FD-2E0E-4D3C-8800-C4E869B861B1Q38089937-F41520C1-B782-4F27-A08F-E7D713D11A57Q38126455-BEBDA1D2-A7C8-4FCA-953E-3ECFAD18E014Q38644639-4526AA61-E228-4AB1-83D7-A6B6A703F3A4Q38792909-D1D7C314-9AC9-4F24-A5C0-C440997636EDQ39033362-7A4ECF9F-F090-466B-B770-E01D8539836FQ40046649-B733A3A6-02EA-4AA2-94B9-37D3B3B860C3Q40085054-EF3AA08F-904F-48DD-9AEA-CE39F6510180Q40306609-CEEFECCF-ACA2-4FD1-A934-C738010693E8Q40504989-9E80C76C-6AD6-4DA9-A59E-81D20C62EF69Q41579102-2D4E06FE-C472-451C-806B-A2D2D0894D60
P2860
Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human papillomavirus 16-associ ...... lls from dysplastic epithelium
@ast
Human papillomavirus 16-associ ...... lls from dysplastic epithelium
@en
Human papillomavirus 16-associ ...... lls from dysplastic epithelium
@nl
type
label
Human papillomavirus 16-associ ...... lls from dysplastic epithelium
@ast
Human papillomavirus 16-associ ...... lls from dysplastic epithelium
@en
Human papillomavirus 16-associ ...... lls from dysplastic epithelium
@nl
prefLabel
Human papillomavirus 16-associ ...... lls from dysplastic epithelium
@ast
Human papillomavirus 16-associ ...... lls from dysplastic epithelium
@en
Human papillomavirus 16-associ ...... lls from dysplastic epithelium
@nl
P2093
P2860
P356
P1476
Human papillomavirus 16-associ ...... lls from dysplastic epithelium
@en
P2093
Cornelia L Trimble
Denise Frosina
Ferdynand Kos
Jessica Teague
Jodie Tassello
Nicole C Barat
Nicole C Hanson
Rachael A Clark
Ying Jiang
P2860
P304
P356
10.4049/JIMMUNOL.1002756
P407
P577
2010-10-29T00:00:00Z